2016 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014
December 23, 2016

Oncobiologics Issues $8.35 Million of Senior Secured Notes and Warrants to Acquire 1.9 Million Shares as part of Aggregate $10.0 Million Note and 2.3 Million Warrant Offeringmore >

November 14, 2016

Oncobiologics Announces Presentation of Final Data from Phase 1 Clinical Study of ONS-3010 (HUMIRA® Biosimilar)more >

August 31, 2016

Oncobiologics to Present at BioCentury’s NewsMakers in the Biotech Industry Conferencemore >

July 06, 2016

Oncobiologics, Inc. to Present at the 2016 Cantor Fitzgerald 2nd Annual Healthcare Conferencemore >

June 16, 2016

Oncobiologics Announces First CTA Approvals for Global Phase 3 Clinical Program for ONS-3010 (Humira® biosimilar)more >

June 10, 2016

Oncobiologics Announces Separation of Units; Trading of Common Stock and Warrantsmore >

May 18, 2016

Oncobiologics Announces Closing of Initial Public Offering of Unitsmore >

May 12, 2016

Oncobiologics Announces Pricing of Its Initial Public Offering of Unitsmore >